Guild Associates Inc.

Guild Associates Inc., doing business as Guild Biosciences, is a for-profit Subchapter S Corporation manufacturer and federal prime contractor based in Dublin, Ohio, that supplies industrial components, mechanical parts, and specialized equipment to the Department of Defense and other civilian agencies, competing predominantly in full-and-open procurements with no set-aside posture.

Guild Biosciences operates as a pure prime contractor—all 2,323 awards in the source data are prime contracts or grants with no subcontract footprint. The company manufactures hardware, hose assemblies, valves, pump units, cable assemblies, protective covers, brackets, fasteners, and related industrial components primarily serving military logistics and equipment maintenance. Recent representative work includes a $6.29 million Other Transaction Agreement with the Joint PEO Chemical and Biological Defense awarded December 5, 2025, to produce chemical and biological protective ensemble prototypes through December 4, 2027; a $306,718 SBIR Phase I grant from the National Institute of Mental Health awarded September 30, 2025, for a point-of-care anti-retroviral drug adherence impedance spectroscopy device; and a $174,945 SBIR Phase I grant from the Department of Agriculture's National Institute of Bioenergy, Climate, and Environment awarded September 15, 2025, to evaluate enzyme-immobilized biogas production technology. Across contract work, Guild Biosciences manufactures supply items valued at sub-six-figure contract ceilings, with individual purchase orders typically ranging from under $500 to $25,000, though larger delivery orders and IDVs reach into the six figures.

Customer concentration is extreme. The Defense Logistics Agency Land and Maritime division alone accounts for 1,089 awards (47% of the total), followed by DLA Troop Support Construction and Equipment (360 awards), DLA Troop Support Hardware (277 awards), and DLA Aviation (243 awards). Together, these four DLA sub-offices represent 1,969 awards—approximately 85% of the company's award count. The top-five customer agencies by award count account for 89% of awards, but the potential-value ranking reveals an outlier: the Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense holds only seven awards yet anchors $8.28 billion in combined potential value, almost exclusively driven by the December 2025 OTA for chemical-biological protective ensemble prototypes. Excluding that single high-ceiling OTA, the company's core business is tightly concentrated with DLA divisions placing high-volume, low-value purchase orders.

Guild Biosciences holds four active single-award Indefinite Delivery Contracts with DLA Land and Maritime, each capped at $350,000, awarded between April and May 2026. These cover TENON, RLD, RAMP CONN components (mechanical power transmission equipment, NSN 3040015839472), SUPPORT, SPECIAL hardware (NSN 5340016738189), and Electronic Modules (NSN 5963015779641). Delivery order activity across these vehicles is moderate—95, 16, and 10-plus orders respectively—reflecting the DLA's steady but not aggressive draw from these positions.

Activity has grown measurably year over year, from 125 awards in 2022 to 191 in 2025, though 2026 shows only 73 awards through early July in the source snapshot—a trajectory consistent with mid-year reporting rather than decline. Twenty-five awards with ultimate completion dates within the next twenty-four months carry combined potential value of $6.5 million, a modest recompete exposure relative to the vendor's total footprint. Only $325.5 million of the $9.96 billion combined potential value has been obligated to date—3 percent—suggesting many awards are either placeholders, option periods not yet exercised, or OTA ceilings that dwarf realistic delivery volumes.

Guild Biosciences' capability portfolio centers on industrial component manufacturing: hardware, fasteners, hose and tubing assemblies, valves, electrical switches, pump units, cable assemblies, protective covers, filtration elements, and mechanical power transmission equipment. Top NAICS codes reflect this framing: Hardware Manufacturing (324 awards), Rubber and Plastics Hoses and Belting Manufacturing (141 awards), Bolt/Nut/Screw Manufacturing (132 awards), and Other Measuring and Controlling Device Manufacturing (109 awards). The company also maintains a biotechnological research arm, evident from multiple SBIR Phase I and Phase II grants focused on enzyme immobilization technology (Immobizyme platform), biogas production, dairy processing applications, and food safety detection—work that positions the vendor as a hybrid industrial supplier and applied research entity. Federal grant footprint is limited but strategic: SBIR awards from NIMH, USDA National Institute of Bioenergy/Climate/Environment, and USDA Institute of Food Safety and Nutrition (CFDA 10.212).

The vendor competes exclusively in full-and-open, unrestricted procurements; zero awards in the source data carry set-aside designations. This posture reflects the company's competitive standing as an established manufacturer capable of winning against all comers on industrial component procurement—particularly in low-value, high-frequency DLA purchase-order environments where small business set-asides are less common and competitive pricing drives award decisions.